메뉴 건너뛰기




Volumn 27, Issue 4, 2010, Pages 179-183

Effects of the anticonvulsant topiramate on language abilities in people with epilepsy: A cross-sectional study

Author keywords

Anticonvulsant; Language abilities; Neuropsychological tests; Topiramate

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

EID: 84857920582     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700001488     Document Type: Article
Times cited : (3)

References (18)
  • 1
    • 0031126348 scopus 로고    scopus 로고
    • A pharmacological and clinical review on Topiramate, a new antiepileptic drug
    • DOI 10.1006/phrs.1997.0124
    • Perucca E A pharmacological and clinical review of topiramate, a new antiepileptic drug. Pharmacol. Res (1997) 35 (4):241-256. (Pubitemid 27331181)
    • (1997) Pharmacological Research , vol.35 , Issue.4 , pp. 241-256
    • Perucca, E.1
  • 2
    • 44749089243 scopus 로고    scopus 로고
    • Cincotta M Central nervous system adverse effects of new antiepileptic drugs: A meta-analysis of placebo-controlled studies
    • Feb 7 [Epub ahead of print]
    • Zaccara G, Ganemi PF, Cincotta M Central nervous system adverse effects of new antiepileptic drugs: A meta-analysis of placebo-controlled studies. Seizure 2008 Feb 7 [Epub ahead of print].
    • (2008) Seizure
    • Zaccara, G.1    Ganemi, P.F.2
  • 4
    • 0842325642 scopus 로고    scopus 로고
    • Reversible language regression as an adverse effect of topiramate treatment in children
    • Gross-Tsur V, Shalev RS Reversible language regression as an adverse effect of topiramate treatment in children. Neurology (2004). 62(2).299-300. (Pubitemid 38167145)
    • (2004) Neurology , vol.62 , Issue.2 , pp. 299-300
    • Gross-Tsur, V.1    Shalev, R.S.2
  • 5
    • 2342461018 scopus 로고    scopus 로고
    • Topiramate in migraine prevention: Results of a large controlled trial
    • DOI 10.1001/archneur.61.4.490
    • Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group Topiramate in migraine prevention: results of a targe controlled trial. Arch Neurol 2004; 61 (4): 490-5. (Pubitemid 38923736)
    • (2004) Archives of Neurology , vol.61 , Issue.4 , pp. 490-495
    • Silberstein, S.D.1    Neto, W.2    Schmitt, J.3    Jacobs, D.4
  • 6
    • 33644655310 scopus 로고    scopus 로고
    • Topiramate 100 mg/day in migraine prevention: A pooled analysis of double-blind randomised controlled trials
    • Bussone G, Diener HC, Pfeil J, Schwalen S Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract. (2005) 59(8):961-8.
    • (2005) Int J Clin Pract. , vol.59 , Issue.8 , pp. 961-968
    • Bussone, G.1    Diener, H.C.2    Pfeil, J.3    Schwalen, S.4
  • 8
    • 0037354372 scopus 로고    scopus 로고
    • Topiramate, carbamazepine and valproate monotherapy: Double-blind comparison in newly diagnosed epilepsy
    • DOI 10.1034/j.1600-0404.2003.00093.x
    • Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S; EPMN 105 Study Group. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol. Scand (2003) 107: 165-175. (Pubitemid 36398991)
    • (2003) Acta Neurologica Scandinavica , vol.107 , Issue.3 , pp. 165-175
    • Privitera, M.D.1    Brodie, M.J.2    Mattson, R.H.3    Chadwick, D.W.4    Neto, W.5    Wang, S.6
  • 9
    • 0038220938 scopus 로고    scopus 로고
    • Differential cognitive and behavioral effects of topiramate and valproate
    • Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R; CAPSS-027 Study Group. Differential cognitive and behavioral effects of topiramate and valproate. Neurology. 2003 May 13; 60(9):1483-8. (Pubitemid 36554811)
    • (2003) Neurology , vol.60 , Issue.9 , pp. 1483-1488
    • Meador, K.J.1    Loring, D.W.2    Hulihan, J.F.3    Kamin, M.4    Karim, R.5
  • 10
    • 15344345526 scopus 로고    scopus 로고
    • Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: Relationships to blood serum levels and comedication
    • DOI 10.1016/j.yebeh.2004.06.017, PII S1525505004002057
    • Kockelmann E, Elger CE, Helmstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 2004; 5(5):716-21. (Pubitemid 40392589)
    • (2004) Epilepsy and Behavior , vol.5 , Issue.5 , pp. 716-721
    • Kockelmann, E.1    Elger, C.E.2    Helmstaedter, C.3
  • 12
    • 16344367438 scopus 로고    scopus 로고
    • Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy
    • DOI 10.1016/j.yebeh.2005.01.002, PII S1525505005000156
    • Fritz N, GloGlogau S, Hoffmann J, Rademacher M, Elger CE, Helmstaedter C Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav. (2005) ;6(3):373-81. (Pubitemid 40468427)
    • (2005) Epilepsy and Behavior , vol.6 , Issue.3 , pp. 373-381
    • Fritz, N.1    Glogau, S.2    Hoffmann, J.3    Rademacher, M.4    Elger, C.E.5    Helmstaedter, C.6
  • 14
    • 0037426443 scopus 로고    scopus 로고
    • Topiramate and word-finding difficulties in patients with epilepsy
    • Mula M, Trimble MR, Thompson P, Sander JW Topiramate and word-finding difficulties in patients with epilepsy. Neurology. (2003) 60(7):1104-7. (Pubitemid 36418768)
    • (2003) Neurology , vol.60 , Issue.7 , pp. 1104-1107
    • Mula, M.1    Trimble, M.R.2    Thompson, P.3    Sander, J.W.A.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.